Airway diseases
Interstitial lung diseases
Pulmonary vascular diseases
Respiratory critical care
Thematic poster
Cardiovascular morbidities in COPD
Methods :
Endoscopy and interventional pulmonology, General respiratory patient care, Imaging, Epidemiology, Cell and molecular biology
Association of cardiovascular risk with inhaled long-acting anti-muscarinic antagonists in COPD patients with impaired renal function
Y. Cheng(Douliou, Taiwan)
COI
1
Evaluation of vasomotor substances in COPD patients
O. Sadovenko(Kharkiv, Ukraine)
COI
2
Systemic inflammatory profile of patients with acute coronary syndrome and concomitant COPD
3
Can BODE index identify right ventricular dysfunction in COPD patients?
P. Venishetty(WARANGAL, India)
COI
4
Diurnal arterial stiffness in patients with chronic obstructive pulmonary disease of varying severity
G. Dolishnyaya(Saratov, Russian Federation)
COI
5
Determinants of aortic stiffness compared to level of obstruction and staging of COPD
Đ. Ljubičić(Zagreb, Croatia)
COI
6
Aortic stiffness in patients with COPD compared to two control groups of smokers and nonsmokers
Đ. Ljubičić(Zagreb, Croatia)
COI
7
Integrity of Membrane Cell as a Risk Factor of Longer Length of Stay in patients with Cardiopulmonary Disease
D. Gonzalez(Ciudad de México, Mexico)
COI
8
Comorbidity of atherosclerotic diseases in COPD patients.
V. Nevzorova(Vladivostok (Primorsky Krai), Russian Federation)
COI
9
Acute vascular diseases: Prompting admissions and readmissions in COPD patients
R. Kochar(Bikaner (Rajasthan), India)
COI
10
Acute cor pulmonale during acute exacerbations of COPD: a new phenotype?
D. Boyer(Rouen, France)
COI
11
Evaluation of a new cardiac arrhythmias predictor in patients with COPD
A. SAIDANE(TUNIS, Tunisia)
COI
12
Safety of nebivolol and bisoprolol in patients (pts) with COPD and stable angina.
O. Fesenko(Slobozhanske, Ukraine)
COI
13
Cardiovascular safety of fixed dose combination long acting bronchodilators in stable patients with Chronic Obstructive Pulmonary Disease.
S. Ghosh(Leicester (Leicestershire), United Kingdom)
COI
14
Utility of electrical bioimpedance by phase analysis to predict the type of heart failure in patients with COPD
A. Orea-Tejeda(México, Mexico)
COI
15
Platelet activity in patients with COPD and concomitant arterial hypertension
K. Gashynova(Dnipro, Ukraine)
COI
16
Safety and benefits of beta-blockers in chronic obstructive pulmonary disease: a review of current evidence and meta-analysis
R. Villalobos(Manila, Philippines)
COI
17
COPD patients require more health care than heart failure patients
L. Persson(Linköping, Sweden)
COI
18
Risk factors for asymptomatic atrial fibrillation in patients with COPD
E. Samorukova(Moscow, Russian Federation)
COI
19
Increased risk of atrial fibrillation in patients with acute exacerbation of chronic obstructive pulmonary disease and sinus rhythm
A. Hemat(Moenchengladbach, Germany)
COI
20
. . .
